Cite
HARVARD Citation
Mazzarella, L. et al. (n.d.). 83P The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies "pure" IRAEs strongly associated with outcome in a phase I-II trial population. Immuno-oncology technology. p. . [Online].